A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Telomelysin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Oncolys BioPharma
- 31 Aug 2016 Results published in an Oncolys BioPharma media release.
- 03 Jun 2008 Interim results presented at the Annual Meeting of the American Society of Clinical Oncology 2008.
- 04 Apr 2008 New trial record.